Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan/HCTZ vs Telmisartan in Hypertension Non-Responders
NCT02177435Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 1999
- Primary completion
- Sep 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydrochlorothiazide in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Feb 1999; status: completed.
02
Drugs
hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02177435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177435.